Healthcare provider profile · identity verified

Benjamin Tobin, MD

Internal Medicine · MILWAUKEE, WI · NPI 1346292653

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	1215	309
Amlodipine Besylate	Amlodipine Besylate	725	205
Losartan Potassium	Losartan Potassium	473	130
Lisinopril	Lisinopril	394	102
Gabapentin	Gabapentin	333	105
Rosuvastatin Calcium	Rosuvastatin Calcium	314	97
Omeprazole	Omeprazole	311	90
Pantoprazole Sodium	Pantoprazole Sodium	283	78
Levothyroxine Sodium	Levothyroxine Sodium	275	66
Metoprolol Succinate	Metoprolol Succinate	270	66
Albuterol Sulfate Hfa	Albuterol Sulfate	248	68
Metformin Hcl Er	Metformin Hcl	242	67
Ozempic	Semaglutide	230	46
Jardiance	Empagliflozin	223	53
Chlorthalidone	Chlorthalidone	217	67
Mounjaro	Tirzepatide	210	35
Hydrochlorothiazide	Hydrochlorothiazide	206	57
Trazodone Hcl	Trazodone Hcl	192	45
Eliquis	Apixaban	191	46
Allopurinol	Allopurinol	177	43
Carvedilol	Carvedilol	169	36
Fluticasone Propionate	Fluticasone Propionate	162	58
Tamsulosin Hcl	Tamsulosin Hcl	152	43
Metformin Hcl	Metformin Hcl	151	41
Metoprolol Tartrate	Metoprolol Tartrate	150	41
Trulicity	Dulaglutide	148	25
Mirtazapine	Mirtazapine	137	43
Furosemide	Furosemide	131	44
Duloxetine Hcl	Duloxetine Hcl	130	31
Ezetimibe	Ezetimibe	127	32
Spironolactone	Spironolactone	124	43
Potassium Chloride	Potassium Chloride	120	40
Tizanidine Hcl	Tizanidine Hcl	113	31
Zolpidem Tartrate	Zolpidem Tartrate	109	18
Sertraline Hcl	Sertraline Hcl	97	26
Montelukast Sodium	Montelukast Sodium	93	23
Pregabalin	Pregabalin	89	24
Hydralazine Hcl	Hydralazine Hcl	88	25
Famotidine	Famotidine	84	15
Simvastatin	Simvastatin	84	22
Warfarin Sodium	Warfarin Sodium	82	21
Quetiapine Fumarate	Quetiapine Fumarate	80	14
Pravastatin Sodium	Pravastatin Sodium	79	22
Clopidogrel	Clopidogrel Bisulfate	76	22
Baclofen	Baclofen	74	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	74	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	74	19
Escitalopram Oxalate	Escitalopram Oxalate	68	22
Atenolol	Atenolol	63	18
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	62	18
Donepezil Hcl	Donepezil Hcl	58	suppressed
Oxycodone Hcl	Oxycodone Hcl	54	suppressed
Alprazolam	Alprazolam	52	suppressed
Lorazepam	Lorazepam	51	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	14
Esomeprazole Magnesium	Esomeprazole Magnesium	47	11
Hydroxyzine Hcl	Hydroxyzine Hcl	44	19
Memantine Hcl	Memantine Hcl	44	suppressed
Clonidine Hcl	Clonidine Hcl	43	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Lidocaine	Lidocaine	43	16
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	42	39
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	42	14
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	38	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	37	20
Varenicline Tartrate	Varenicline Tartrate	37	suppressed
Xarelto	Rivaroxaban	37	suppressed
Diclofenac Sodium	Diclofenac Sodium	35	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Meloxicam	Meloxicam	34	15
Tramadol Hcl	Tramadol Hcl	34	11
Linzess	Linaclotide	32	suppressed
Ibuprofen	Ibuprofen	31	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	15
Azithromycin	Azithromycin	29	28
Bupropion Xl	Bupropion Hcl	29	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	suppressed
Methocarbamol	Methocarbamol	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Aripiprazole	Aripiprazole	26	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	26	suppressed
Klor-Con M20	Potassium Chloride	26	suppressed
Prednisone	Prednisone	26	15
Celecoxib	Celecoxib	25	suppressed
Methylprednisolone	Methylprednisolone	25	23
Finasteride	Finasteride	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	19
Amitriptyline Hcl	Amitriptyline Hcl	23	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	23	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	23	suppressed
Topiramate	Topiramate	23	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	22	suppressed
Irbesartan	Irbesartan	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Divalproex Sodium Er	Divalproex Sodium	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Naloxone Hcl	Naloxone Hcl	21	16
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	20	suppressed
Nifedipine Er	Nifedipine	20	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	20	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	20	suppressed
Nystop	Nystatin	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	suppressed
Testosterone	Testosterone	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Lacosamide	Lacosamide	17	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Repatha Syringe	Evolocumab	17	suppressed
Bumetanide	Bumetanide	16	suppressed
Felodipine Er	Felodipine	16	suppressed
Lubiprostone	Lubiprostone	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	16	suppressed
Solifenacin Succinate	Solifenacin Succinate	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Clonazepam	Clonazepam	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Fluconazole	Fluconazole	15	11
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Nystatin	Nystatin	15	suppressed
Glipizide Er	Glipizide	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Nateglinide	Nateglinide	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Valsartan	Valsartan	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Savella	Milnacipran Hcl	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Ammonium Lactate	Ammonium Lactate	12	suppressed
Aplenzin	Bupropion Hbr	12	suppressed
Estazolam	Estazolam	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Glipizide	Glipizide	12	suppressed
Nitroglycerin	Nitroglycerin	12	suppressed
Rybelsus	Semaglutide	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Alendronate Sodium	Alendronate Sodium	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Hyzaar	Losartan/Hydrochlorothiazide	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Victoza 3-Pak	Liraglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error